[Methicillin-resistant Staphylococcus aureus. Types of resistance and clinical consequences]

U Geipel1, M Herrmann

  • 1Institute für Infektionsmedizin, Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum des Saarlandes, Homburg/Saar. bhugei@uniklinik-saarland.de

Der Anaesthesist
|January 29, 2005
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a growing global threat, with regional variations in strains and resistance. Effective control requires tailored strategies for early recognition, infection control, and antimicrobial therapy, especially in intensive care units.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Context:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant and increasing global health challenge.
  • Regional variations in MRSA incidence, prevalent strains, resistance patterns, and epidemic control resources complicate management.
  • Intensive care units (ICUs) are frequent epicenters for MRSA outbreaks, necessitating specialized attention.

Purpose:

  • To outline essential knowledge and adaptive strategies for healthcare professionals managing MRSA.
  • To emphasize the need for tailored approaches to MRSA prevention and therapy based on local conditions.
  • To promote a rational, cost-effective strategy for controlling this nosocomial pathogen.

Summary:

  • Healthcare providers, particularly anaesthetists, intensive care physicians, and surgeons, must be knowledgeable about MRSA.
  • Key areas include early recognition, infection control, antimicrobial therapy principles, and adapting guidelines to institutional needs.
  • A rational, efficient, and cost-effective approach is crucial for managing MRSA in healthcare settings.

Impact:

  • Facilitates improved clinical decision-making in MRSA patient care.
  • Supports the development of localized, evidence-based MRSA control programs.
  • Aims to reduce the burden of MRSA infections in critical care environments and beyond.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antibiotic Selection00:57

Antibiotic Selection

Overview